Rajiv C Patel1, Saleem Kamili2, Eyasu Teshale2. 1. Oak Ridge Institute for Sciences and Education, United States. Electronic address: rajiv.c.patel@gmail.com. 2. Division of Viral Hepatitis, Centers for Disease Control and Prevention, United States.
Abstract
BACKGROUND: The epidemiology of hepatitis E virus (HEV) infections among children is not well understood, with some studies reporting that hepatitis E infections do not affect children. OBJECTIVES: We analyzed seroepidemiologic data collected during a hepatitis E outbreak in Uganda to determine prevalence of past and recent HEV infections among children aged 0-15 years. STUDY DESIGN: Individuals were randomly selected from a household census to participate in a seroprevalence survey. We analyzed data on IgM and IgG antibody to HEV among children aged 0-15 years. We categorized the study population by age group [aged 0-5, 6-10, and 11-15 years], and further stratified the youngest children [aged 0-1, 2-3, and 4-5 years]. Presence of IgG anti-HEV alone indicated past HEV infection, whereas recent infection was defined as presence of IgM anti-HEV with or without IgG anti-HEV. RESULTS: Among children aged 0-15 years (N=244), prevalence of past HEV infection was 25.4% (62/244) and was highest among children aged 0-5 years [31.0% (27/87)]. Evidence of recent HEV infection was detected in 37.3% (91/244) of children aged 0-15 years. Among younger children, recent HEV infection increased with age from 4.3% (1/23) in children aged 0-1 year to 36.7% (11/30) in children aged 4-5 years. CONCLUSION: These data show that children are not spared from HEV infections. Illness during childhood in developing countries is common and HEV infections may be misdiagnosed as another acute illness, or under diagnosed. The lack of clinical care, HEV diagnostics, and surveillance in developing countries limit our full understanding of hepatitis E epidemiology.
BACKGROUND: The epidemiology of hepatitis E virus (HEV) infections among children is not well understood, with some studies reporting that hepatitis E infections do not affect children. OBJECTIVES: We analyzed seroepidemiologic data collected during a hepatitis E outbreak in Uganda to determine prevalence of past and recent HEV infections among children aged 0-15 years. STUDY DESIGN: Individuals were randomly selected from a household census to participate in a seroprevalence survey. We analyzed data on IgM and IgG antibody to HEV among children aged 0-15 years. We categorized the study population by age group [aged 0-5, 6-10, and 11-15 years], and further stratified the youngest children [aged 0-1, 2-3, and 4-5 years]. Presence of IgG anti-HEV alone indicated past HEV infection, whereas recent infection was defined as presence of IgM anti-HEV with or without IgG anti-HEV. RESULTS: Among children aged 0-15 years (N=244), prevalence of past HEV infection was 25.4% (62/244) and was highest among children aged 0-5 years [31.0% (27/87)]. Evidence of recent HEV infection was detected in 37.3% (91/244) of children aged 0-15 years. Among younger children, recent HEV infection increased with age from 4.3% (1/23) in children aged 0-1 year to 36.7% (11/30) in children aged 4-5 years. CONCLUSION: These data show that children are not spared from HEV infections. Illness during childhood in developing countries is common and HEV infections may be misdiagnosed as another acute illness, or under diagnosed. The lack of clinical care, HEV diagnostics, and surveillance in developing countries limit our full understanding of hepatitis E epidemiology.
Authors: Ashish C Shrestha; Robert L P Flower; Clive R Seed; Manita Rajkarnikar; Shrawan K Shrestha; Uru Thapa; Veronica C Hoad; Helen M Faddy Journal: BMC Infect Dis Date: 2016-11-25 Impact factor: 3.090
Authors: Alexander Spina; Annick Lenglet; David Beversluis; Marja de Jong; Larissa Vernier; Craig Spencer; Fred Andayi; Charity Kamau; Simone Vollmer; Boris Hogema; Andrea Irwin; Roger Ngueremi Yary; Açyl Mahamat Ali; Ali Moussa; Prince Alfani; Sibylle Sang Journal: PLoS One Date: 2017-11-27 Impact factor: 3.240
Authors: Aybüke Koyuncu; Daniel Mapemba; Iza Ciglenecki; Emily S Gurley; Andrew S Azman Journal: Open Forum Infect Dis Date: 2021-04-13 Impact factor: 3.835